A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 44
Summary
- Conditions
- Melanoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02975700
- Collaborators
- Daiichi Sankyo, Inc.
- Investigators
- Study Director: Global Clinical Leader Daiichi Sankyo, Inc.